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a b s t r a c t
Several diffusion tensor imaging (DTI) studies have reported disturbed white matter integrity in various
brain regions in patients with schizophrenia, whereas only a few studied the effect of antipsychotics on DTI
measures. The aim of this study was to investigate the effect of 12 weeks of clozapine treatment on DTI
findings in patients with schizophrenia, and to compare the findings with those in unaffected controls. The
study included 16 patients with schizophrenia who were assessed with the Positive and Negative Syndrome
Scale, a neurocognitive test battery, and DTI at baseline and 12 weeks after the initiation of clozapine
treatment. Eight unaffected controls were assessed once with the neurocognitive test battery and DTI. Voxel-
wise analysis of DTI data was performed via tract-based spatial statistics (TBSS). Compared with the control
group, the patient group exhibited lower fractional anisotropy (FA) in 16 brain regions, including the bilateral
superior longitudinal fasciculi, inferior fronto-occipital fasciculi, superior and inferior parietal lobules,
cingulate bundles, cerebellum, middle cerebellar peduncles, and left inferior longitudinal fasciculus, whereas
the patients had higher FA in six regions, including the right parahippocampus, left anterior thalamic
radiation, and right posterior limb of the internal capsule before clozapine treatment. After 12 weeks of
treatment with clozapine, white matter FA was increased in widespread brain regions. In two of the regions
where FA had initially been lower in patients compared with controls (left inferior fronto-occipital fasciculus
and superior parietal lobule), clozapine appeared to increase FA. An improvement in semantic fluency was
correlated with the increase in FA value in the left inferior fronto-occipital fasciculus. An increase in FA
following 12 weeks of treatment with clozapine suggests that this treatment alters white matter
microstructural integrity in patients with schizophrenia previously treated with typical and/or atypical
antipsychotics and, in some locations, reverses a previous deficit.
& 2014 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Neuroimaging and neurophysiological studies suggest that a
disturbance in connectivity between different brain regions is
responsible for the clinical symptoms of schizophrenia (Bramon
et al., 2004; Meyer-Lindenberg et al., 2005). Dysconnectivity is
thought to result from aberrant wiring of connections during
development, and from aberrant synaptic plasticity. Findings of
dysconnectivity (Meyer-Lindenberg et al., 2005) and white matter
abnormalities (Dracheva et al., 2006) in the brains of patients with
schizophrenia have led to an increase in the use of diffusion tensor
imaging (DTI), a magnetic resonance imaging (MRI) technique
used to evaluate structural connectivity in the human brain in
specific white matter bundles. Fractional anisotropy (FA) is a DTI
parameter widely used to indicate the motional anisotropy of
water molecules; a reduction in FA may be indicative of white
matter impairment (Beaulieu, 2002; Assaf and Pasternak, 2008).
Numerous DTI studies have compared findings in patients with
schizophrenia with findings in normal controls, and most have
observed lower FA in diverse white matter regions in patients than
in controls (Kubicki et al., 2005; Kanaan et al., 2005; Buchsbaum
et al., 2006a; Mitelman et al., 2006; Ellison-Wright and Bullmore,
2009). The corpus callosum, cingulum, uncinate fasciculus, super-
ior and inferior longitudinal fasciculus, fornix, and anterior limb of
the internal capsule are some of the brain regions that have
frequently been reported to have lower FA, based on region of
interest (ROI) studies (Foong et al., 2000; Sun et al., 2003;
Buchsbaum et al., 2006b; Ashtari et al., 2007; Mori et al., 2007;
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Price et al., 2008; Karlsgodt et al., 2008; Fitzsimmons et al., 2009).
Voxel-based studies that have analyzed white matter throughout
the brain, rather than preselecting limited regions of the brain for
analysis, report even more brain regions with lower FA (Ellison-
Wright and Bullmore, 2009; Melonakos et al., 2011; Sugranyes
et al., 2012; Roalf et al., 2013). In a meta-analysis of 15 voxel-based
DTI studies, 407 patients with schizophrenia were compared with
383 controls, and 112 coordinates with lower FA (number of
coordinates in the studies ranging from 2 to 19) were detected
in the patients (Ellison-Wright and Bullmore, 2009). A more recent
meta-analysis of 23 studies reported inconsistent findings, with
coordinates representing low FA scattered across the brain in
patients with schizophrenia; the genu and splenium of the corpus
callosum, the right anterior corona radiata, and the posterior
thalamic radiation bilaterally were the most frequently reported
regions (Melonakos et al., 2011).
Differences in reports of low FA in patients with schizophrenia
have been associated with methodological and clinical differences,
and the possible effects of antipsychotics (Buchsbaum et al.,
2006b; Kubicki et al., 2007; Konrad and Winterer, 2008;
Melonakos et al., 2011; Henze et al., 2012). Although the effect of
antipsychotics on DTI measures is an important parameter that
should be controlled for when interpreting relevant findings, our
knowledge of the effect is quite limited. Some cross-sectional
studies on the relationship between antipsychotic dose and FA
values found that there was not an association (Foong et al., 2000),
whereas others reported a negative association (Kuroki et al.,
2006) or a positive association (Minami et al., 2003; Okugawa
et al., 2004). The literature includes only two longitudinal follow-
up studies on the effects of antipsychotics on DTI. Garver et al.
(2008) assessed whole-brain mean diffusivity (Dm) in 13 acutely
psychotic, drug-free patients with schizophrenia before and after
28 days of antipsychotic drug treatment (risperidone, ziprasidone,
or haloperidol), and reported that there was a significant decrease
in Dm in the right pyramidal tract, left temporal lobe, and
cingulate gyrus in the treatment responders. In the second study,
first episode drug-naïve patients with schizophrenia were
reported to have a significant decrease in FA of white matter
around the bilateral anterior cingulate gyrus and the right corona
radiata of the frontal lobe compared with controls, following
6 weeks of antipsychotic treatment that included several typical
and atypical antipsychotics (Wang et al., 2013).
Antipsychotic drugs induce anatomical and molecular changes
in the brain, and their effect on neuroplasticity via modification of
synaptic connections is thought to be important to their mechan-
ism of action (Konradi and Heckers, 2001). Clozapine is a proto-
typical atypical antipsychotic that has been shown to be effective
in the treatment of refractory schizophrenia (Kane et al., 1988;
McEvoy et al., 2006). Preclinical studies have found that clozapine
has a positive effect on neuroplasticity (Critchlow et al., 2006) and
myelin integrity (Xu et al., 2009; Xu et al., 2010). Structural
imaging studies showed that clozapine could reverse the increase
in basal ganglia volume induced by typical antipsychotics (Chakos
et al., 1995) and that the reduction in the severity of negative
symptoms in response to clozapine was associated with an
increase in right prefrontal gray matter volume (Arango et al.,
2003). A magnetic resonance spectroscopy (MRS) study reported
that 8 weeks of clozapine treatment resulted in an increase in the
N-acetyl aspartate/creatine ratio in the left dorsolateral prefrontal
cortex, which was considered evidence of the positive effects of
clozapine on neuronal functioning and integrity (Ertugrul et al.,
2009). In that study the left dorsolateral prefrontal cortex was the
only region studied with MRS and no data regarding possible
alterations in other brain regions were obtained. Clozapine was
also shown to affect brain metabolism and function in multiple
brain regions. An animal study found that clozapine caused
metabolic changes in 32 brain regions acutely and 19 regions
chronically (Wotanis et al., 2003). Human neuroimaging studies
showed that clozapine had effects in various brain regions,
including the limbic cortex (Cohen et al., 1997), hippocampus
(Lahti et al., 2003), anterior cingulate cortex (Lahti et al., 2004),
and components of the fronto-striato-thalamic pathway, especially
the prefrontal cortex (Molina Rodríguez et al., 1996; Lahti et al.,
2003; Ertugrul et al., 2009).
To the best of our knowledge, no study has investigated the
effect of clozapine treatment on white matter integrity based on
DTI measures. In view of the results of preclinical and clinical
studies, it is plausible to expect that clozapine will alter connec-
tivity by changing white matter integrity. As such, the aim of the
present study was to investigate the effect of 12 weeks of
clozapine treatment on white matter in patients with schizophre-
nia based on DTI measures, and to compare the findings with
those in unaffected controls. A whole-brain approach was chosen
for the following reasons: (1) Patients with schizophrenia have
been reported to have lower FA in multiple brain regions com-
pared with controls (Kubicki et al., 2005; Kanaan et al., 2005;
Buchsbaum et al., 2006a; Mitelman et al., 2006; Ellison-Wright
and Bullmore, 2009). (2) The results of earlier neuroimaging
studies on clozapine have indicated effects in multiple brain
regions, not in any specific anatomical region (Molina Rodríguez
et al., 1996; Cohen et al., 1997; Lahti et al., 2003; Lahti et al., 2004;
Ertugrul et al., 2009). (3) As the first DTI study on the effect of
clozapine in patients with schizophrenia, the present exploratory
study aimed to detect all probable changes anywhere in brain via
voxel-based analysis. For voxel-based analysis, the present study
used tract-based spatial statistics (TBSS), which is suggested to
improve the sensitivity, objectivity, and interpretability of the
analysis of multi-subject diffusion imaging (Smith et al., 2006),
and is increasingly being used in the study of white matter
organization in patients with schizophrenia (Chen et al., 2013; Lee
et al., 2013; Roalf et al., 2013).
2. Methods
2.1. Participants
This study was conducted at the Department of Psychiatry in the Hacettepe
University School of Medicine. The study included 16 consecutive outpatients
diagnosed with schizophrenia based on DSM-IV criteria that were treated with
clozapine due to treatment refractoriness or intolerance to previous typical and/or
atypical antipsychotics. In addition, eight unaffected controls matched to the
patients on age, gender, and level of education were recruited for the study.
Exclusion criteria were alcohol or drug abuse/dependency, any major medical or
neurological disorder, and history of head trauma that would affect neuroradiolo-
gical assessment. The study protocol was approved by the Hacettepe University
School of Medicine Ethics Committee (LUT 10/02), and all participants gave
informed consent. The Structured Clinical Interview for DSM Disorders (First,
1997; Corapcioglu et al., 1999) was used to confirm the patients' diagnoses and
to exclude any Axis-I disorder in the controls. Table 1 presents the demographic
and clinical characteristics of the two groups.
2.2. Procedure
Psychopathology, neurocognitive functioning, and DTI in the patient group
were assessed at baseline while the patients were using their current antipsychotic
medication, and again 12 weeks after the initiation of clozapine treatment.
Psychopathology was assessed using the Positive and Negative Syndrome Scale
(PANSS) (Kay et al. 1987; Kostakoglu et al., 1999) and the Clinical Global Impression
Scale (CGIS). The neuropsychological test battery included the following tests: Digit
Span Test (Wechsler, 1987); Auditory Consonant Trigram Test (Anil et al., 2003);
Word and Category Fluency Test (Benton and Hamsher, 1978); Rey Auditory-Verbal
Learning Test (RAVLT) (Lezak, 1995); Wechsler Visual Memory Scale-Visual Repro-
duction Scale (Wechsler, 1987); and Trail Making A and B (Spreen and Strauss,
1998).
Clozapine treatment was initiated following baseline assessment, and the
current antipsychotic medication was discontinued following gradual tapering.
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The clozapine dose was titrated according to each patient's clinical status. The
mean clozapine dose at week 12 of treatment was 317.19798.62 mg/day. All
patients completed the assessment after 12 weeks of treatment. The patients’white
blood cell counts were assessed weekly. No serious adverse effects were observed.
Controls were assessed once with DTI and the neuropsychological test battery.
2.3. Diffusion tensor imaging
2.3.1. Image acquisition
All participants that met the inclusion criteria underwent structural MRI with
DTI of the brain using a 1.5-Tesla scanner equipped with a 30 mT/m gradient
system and an eight-channel phase-array head coil (Symphony, Tim, Siemens,
Erlangen, Germany). Sagittal and axial T1-weighted images (repetition time (TR)/
echo time (TE: 500/50 ms; matrix: 192256; slice thickness: 5 mm; interslice gap:
10%) and axial T2-weighted images (TR/TE: 4500/100 ms; matrix: 192256; slice
thickness: 3 mm; interslice gap: 0) were obtained to exclude the presence of
lesions and to obtain anatomical data for DTI planning.
DTI was performed using a single-shot echo-planar imaging sequence in the axial
plane, parallel to the anterior–posterior commissures covering the entire brain (TR/TE:
5814 /98 ms; maximum b factor: 1000 s/mm2; 64 independent directions; field of
view: 23 cm; matrix: 128128; slice thickness: 3 mm; interslice gap: 0).
2.3.2. Processing and analysis of DTI data
TBSS (Smith et al., 2006)—included in the FSL v.4.0 software package (Centre for
Functional MR Imaging of the Brain, Oxford University, Oxford, UK, http://www.
fmrib.ox.ac.uk/fsl)—was used for whole-brain voxel-wise statistical analysis. Pre-
processing of the diffusion-weighted data included correction of head motion and
Eddy current, diffusion tensor fitting (FSL DTIFit), and calculation of FA maps. FA
maps were registered and aligned to the average space as input for TBSS, and the
mean FA skeleton was computed. A permutation-based inference with 500
permutations was performed for voxel-wise statistics on FA. Then, threshold-free
cluster enhancement output was obtained and corrected for multiple comparisons.
Family-wise error (FWE)-corrected maps were obtained with P values o0.05.
Then, cluster-based thresholding was performed, which included Gaussian
smoothing, application of a threshold (t: 1.5), and forming clusters from 26
neighboring suprathreshold voxels. TBSS maps were obtained for the following
two comparisons: (1) Patients vs. controls at baseline; (2) Patients at baseline vs.
patients following clozapine treatment.
White matter coordinates of clusters with significant FA change on the
corrected threshold-cluster extent voxel maps were extracted as regions of interest
(ROIs), and were registered to and overlaid onto an anatomical Montreal Neurology
Institute (MNI) template (www.fmrib.ox.ac.uk/fsl/data/FMRIB58). The ROIs were
noted according to the Johns Hopkins University WM tractography atlas and the
International Consortium for Brain Mapping DTI-81 WM atlas, which are available
in FSL. Next, mean FA of the ROIs was calculated for each participant to be used in
correlational analysis.
2.4. Statistical analysis
Statistical analysis was performed using SPSS v.15.0 for Windows. Comparisons
of baseline FA values in the patient and control groups, and of the FA values in the
patients before clozapine and after clozapine treatment, were performed via the
TBSS method (family-wise error (FWE)-corrected, Po0.05). Patients and controls
were compared using the Mann–Whitney U-test for numerical variables and the
chi-square test for nominal variables. The normality of PANSS, CGIS, and neuro-
cognitive test scores in the patients was assessed using the Shapiro–Wilk test, and
in cases of normal variance the paired sample t-test was used; otherwise, the
Wilcoxon-signed rank test was used to compare PANSS, CGIS, and neurocognitive
scores in the patients before and after clozapine treatment. The relationships
between changes in PANSS, CGIS, and neurocognitive test scores, and changes in FA
scores after 12 weeks of clozapine treatment, were evaluated using Spearman's
correlation analysis. Correction for multiple comparisons was done for correlational
analysis by the Machado method (Machado, 2007). The adjusted significance
threshold, α, was 0.004 for correlational analysis.
3. Results
3.1. Demographic and clinical characteristics of the study groups
There were not any significant differences in mean age, level of
education, or gender ratio between the schizophrenia and control
groups (Table 1). The comparison of baseline and week-12 psy-
chopathology assessments in the schizophrenia group showed
that the PANSS total score, as well as the PANSS positive, negative,
and general psychopathology subscale scores, improved signifi-
cantly (Po 0.001), as did the CGIS score (P¼0.001) (Table 2). In
terms of neurocognitive test performance, the patients had sig-
nificantly lower word fluency (P¼0.038), category fluency (animal
(P ¼0.027), name (P ¼0.000), and alternation (P¼0.000)) scores,
auditory consonant trigrams (ACT) score (P¼0.016), RAVLT
immediate memory (P¼0.045), RAVLT learning (P¼0.023), and
RAVLT cumulative learning (P¼0.011) scores, Trail Making-A score
(P¼0.006), and visual reproduction-delayed recall score
(P¼0.027) than the controls at baseline. Significant improvement
in category fluency name (P¼0.045) and alternation scores
(P¼0.045), RAVLT immediate memory (P¼0.019) and RAVLT
learning scores (P¼0.004), and visual reproduction-delayed recall
score (P¼0.001) was observed in the patient group after 12 weeks
of clozapine treatment (Table 2).
3.2. Comparison of baseline FA measures in the schizophrenia
and control groups
TBSS showed that FA was significantly lower at baseline in 16
regions (including the bilateral superior longitudinal fasciculi,
inferior fronto-occipital fasciculi, cingulate bundles, inferior par-
ietal lobules, superior parietal lobules, cerebellum, middle cere-
bellar peduncles, left inferior longitudinal fasciculus, and sagittal
stratum) in the patient group than in the control group. On the
other hand, TBSS showed that FA was significantly higher at
baseline in six regions (including the right parahippocampus,
posterior limb of the internal capsule, sagittal stratum, left anterior
thalamic radiation, and bilateral optic radiation) in the patient
group than in the control group. Fig. 1 shows the regions that
differed significantly (Po0.05) between the two groups according
to TBSS. The coordinates and the mean FA values for these regions
are shown in Table 3.
3.3. Comparison of FA measures at baseline and after 12 weeks
of clozapine treatment in the patients with schizophrenia
As compared with baseline values, TBSS showed that FA in the
patient group increased significantly after 12 weeks of clozapine
treatment in 31 brain regions, including the corpus callosum,
bilateral inferior longitudinal fasciculi, uncinate fasciculi, thala-
mus, left parahippocampus, fornix, cingulate bundle, inferior
fronto-occipital fasciculus, superior parietal lobule, and cerebel-
lum. There was no brain region in which FA decreased after
Table 1
Demographic and clinical variables of the study groups.
Patients (n¼16) Controls (n¼8) Analysis
Mean (S.D.) Mean (S.D.) p




Years of education 10.94 (3.66) 11.38 (3.20) 0.88
Age of onset 22.25 (7.46)
Duration of illnessa 11.62 (9.17)
Hospitalization number 1.81 (1.60)






Clozapine dose, mg/day 317.19 (98.62)
a Years.
b Chlorpromazine-equivalent dosage at baseline.
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clozapine treatment. Fig. 2 shows the regions with a significant
increase in FA (Po0.05) between baseline and 12 weeks of
clozapine treatment according to TBSS; the coordinates and the
mean FA values for these regions are presented in Table 4.
The effect of clozapine treatment on the regions that were
found to be significantly different between patients at baseline and
controls by TBSS (the regions presented in Table 3) was examined
in an additional analysis. The mean FA values of the same cluster of
voxels were calculated for post-clozapine data in patients with
schizophrenia. The baseline and week-12 FA values of these
regions were compared by paired samples t-test, and significant
increases in the FA in the left superior parietal lobule (t¼2.37,
Po0.05) and the left inferior fronto-occipital fasciculus (t¼6.12,
Po0.001) were detected.
3.4. Relationship between change in FA values and change
in psychopathology and neurocognitive scores
The correlations between FA values and psychopathology and
neurocognitive test scores that significantly changed after
clozapine treatment were computed. Improvement in category
fluency was significantly correlated with the observed increase in
FA in the left inferior fronto-occipital fasciculus after correction for
multiple comparisons (r¼0.738, P¼0.001) (Fig. 3). There were no
other significant correlations between the change in FA values and
psychopathology and neurocognitive test scores after correction
for multiple comparisons.
4. Discussion
The aim of the present study was to investigate the effect of
clozapine on white matter integrity in patients with schizophrenia
based on measurement of FA, and to compare FA values in patients
with schizophrenia with values in controls. The present findings
show that the patients with schizophrenia had lower baseline FA
values than the controls in 16 regions, including the left inferior
longitudinal fasciculus, bilateral superior longitudinal fasciculi,
inferior fronto-occipital fasciculi, cingulate bundles, superior
and inferior parietal lobules, cerebellum, and middle cerebellar
Table 2
The clinical and neuropsychological results of the study groups.
Controls n¼8 Patients (visit 1) n¼16 Patients (visit 2) n¼16 Statistics
Mean (S.D.) Mean (S.D.) Mean (S.D.) Control/visit 1a Visit 1/Visit 2b,c
PANSS total 83.25 (12.57) 56.31 (12.19) t¼7.087b
p¼0.000
PANSS positive 22.44 (4.03) 12.44 (3.58) t¼7.402b
p¼0.000
PANSS negative 21.06 (4.15) 16.00 (3.86) t¼5.589b
p¼0.000
PANSS general psychopathology 39.75 (6.94) 28.19 (6.40) t¼6.829b
p¼0.000
CGI-S 4.62 (0.81) 2.81 (0.91) z¼3.449c
p¼0.001
Word fluency 28.62 (9.41) 18.44 (10.87) 21.62 (12.74) z¼2.085 z¼ 1.877c
p¼0.038 p¼0.061
Category fluency-animal 19.88 (4.29) 14.81 (6.53) 14.31 (7.31) z¼2.179 z¼0.126c
p¼0.027 p¼ 0.900
Category fluency-name 24.25 (3.01) 15.38 (6.08) 17.19 (5.89) z¼3.283 z¼2.000c
p¼ 0.000 p¼0.045
Category fluency-alternation 9.12 (1.80) 4.69 (2.60) 6.06 (2.72) z¼3.289 z¼2.611c
p¼ 0.000 p¼ 0.009
Digit span-forward 6.00 (1.77) 5.44 (2.10) 6.00 (2.42) z¼0.475 z¼ 1.557c
p¼ 0.653 p¼ 0.120
Digit span-backward 5.88 (2.90) 4.31 (1.99) 4.62 (1.96) z¼1.238 z¼0.914c
p¼0.238 p¼ 0.361
Digit span total 11.88 (4.36) 9.75 (3.47) 10.62 (4.10) z¼0.954 z¼ 1.878c
p¼0.350 p¼ 0.060
ACT 47.50 (8.32) 36.25 (10.45) 38.81 (8.40) z¼2.361 z¼1.427c
p¼0.016 p¼ 0.154
RAVLT-immediate recall 6.50 (1.77) 4.75 (1.81) 6.12 (2.03) z¼2.018 t¼2.627b
p¼0.045 p¼0.019
RAVLT-5 learning 11.00 (2.07) 8.25 (2.89) 8.81 (2.93) z¼2.285 t¼1.013b
p¼ 0.023 p¼0.327
RAVLT 1-5 cumulative learning 47.50 (10.10) 33.75 (11.91) 39.2 (13.07) z¼2.483 t¼3.40b
p¼ 0.011 p¼0.004
RAVLT- delayed recall 9.12 (3.27) 7.19 (2.74) 6.4 (2.94) z¼1.392 t¼1.441b
p¼0.172 p¼ 0.170
WMS-visual reproduction-immediate 31.38 (4.14) 25.88 (9.08) 27.25 (8.97) z¼1.472 z¼0.804c
p¼0.153 p¼0.422
WMS-visual reproduction-delayed 28.50 (6.52) 18.94 (10.39) 26.25 (10.12) z¼2.213 z¼3.184c
p¼0.027 p¼0.001
Trail making A- time 31.00 (7.78) 69.50 (65.55) 63.12 (66.78) z¼2.696 z¼1.657
p¼0.006 p¼0.098
Trail making B-time 100.00 (65.06) 135.54 (78.78) 103.00 (57.62) z¼0.991 z¼ 1.836
p¼0.351 p¼0.066
a Mann–Whitney U-test.
b Paired samples t-test.
c Wilcoxon signed-rank test. ACT: Auditory Consonant Trigram. RAVLT: Rey's Auditory–Verbal Learning Test, WMS: Wechsler Memory Scale
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peduncles, and that after 12 weeks of clozapine treatment, FA
values in the patients with schizophrenia increased in 31 regions,
including the splenium, genu and the body of the corpus callosum,
bilateral inferior longitudinal fasciculi, uncinate fasciculi, thala-
mus, anterior thalamic radiation, middle cerebellar peduncles,
left superior longitudinal fasciculus, inferior fronto-occipital
fasciculus, parahippocampus, fornix, cingulate bundle, superior
parietal lobule and cerebellum.
The observation that at baseline, FA was lower in multiple brain
regions in patients with schizophrenia in this study is in accor-
dance with earlier DTI studies that have consistently reported
lower FA in various white matter regions in patients with
Fig. 1. TBSS (FWE-corrected threshold-cluster extend voxel P maps) show regions of significantly lower (in red) and higher (in blue) FA in patients with schizophrenia, as
compared to gender- and age-matched controls (Po0.05). An FA skeleton projected onto a mean FA map is shown in green. (For interpretation of the references to color in
this figure legend,the reader is referred to the web version of this article)
Table 3
The mean FA values and MNI coordinates of the brain regions which are significantly different in patients at baseline compared with controls according to TBSS (FWE
corrected, Po0.05).
Regions of brain MNI coordinates Patients (visit 1) (n¼16) Controls (n¼8)
x y z Mean (S.D.) Mean (S.D.)
Schizophrenia FAo control FA
Superior longitudinal fasciculus (R) 44 78 73 0.422 (0.127) 0.443 (0.105)
Superior longitudinal fasciculus (L) 143 80 70 0.302 (0.149) 0.381 (0.100)
Inferior longitudinal fasciculus(L) 137 108 53 0.336 (0.010) 0.362 (0.087)
Inferior frontooccipital fasciculus (R) 49 156 66 0.235 (0.086) 0.269 (0.076)
Inferior frontooccipital fasciculus (L) 112 152 68 0.279 (0.067) 0.308 (0.055)
Sagittal stratum (L) 124 90 80 0.540 (0.099) 0.576 (0.051)
Cingulum (R) 82 94 109 0.287 (0.067) 0.318 (0.089)
Cingulum (L) 99 96 109 0.306 (0.099) 0.357 (0.143)
Inferior parietal lobule (R) 36 92 89 0.255 (0.108) 0.366 (0.129)
Inferior parietal lobule (L) 135 64 86 0.240 (0.108) 0.276 (0.124)
Superior parietal lobule (R) 77 81 131 0.233 (0.099) 0.280 (0.121)
Superior parietal lobule (L) 104 88 112 0.184 (0.082) 0.292 (0.092)
Cerebellum (R) 58 61 38 0.260 (0.061) 0.303 (0.083)
Cerebellum(L) 126 65 38 0.225 (0.056) 0.256 (0.079)
Middle cerebellar peduncle (R) 74 93 41 0.555 (0.101) 0.572 (0.071)
Middle cerebellar peduncle (L) 101 90 41 0.466 (0.083) 0.479 (0.078)
Schizophrenia FA4control FA
Parahippocampus(R) 63 105 49 0.257 (0.030) 0.245 (0.023)
Optic radiation (R) 72 31 80 0.252 (0.050) 0.239 (0.091)
Optic radiation (L) 109 35 77 0.238 (0.071) 0.192 (0.059)
Posterior limb of internal capsule (R) 71 114 76 0.673 (0.068) 0.667 (0.035)
Anterior thalamic radiation (L) 114 153 89 0.328 (0.043) 0.319 (0.064)
Sagittal stratum (R) 58 57 75 0.403 (0.068) 0.358 (0.071)
L: left. R: right
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Fig. 2. TBSS (FWE-corrected threshold-cluster extend voxel P maps) shows regions with significantly higher FA (in blue) in patients with schizophrenia following 12 weeks
of clozapine treatment, as compared to baseline (Po0.05). An FA skeleton projected onto a mean FA map is shown in green. (For interpretation of the references to color in
this figure legend,the reader is referred to the web version of this article)
Table 4
The mean FA values and MNI coordinates of the brain regions which are significantly different in patients at week 12 of clozapine treatment compared with baseline
according to TBSS (FWE corrected, Po0.05).
Regions of brain MNI coordinates Before clozapine (visit 1) (n¼16) After clozapine (visit 2) (n¼16)
After clozapine FA4Before clozapine FA x y z Mean (S.D.) Mean (S.D.)
Parahippocampus (L) 119 102 50 0.212 (0.043) 0.227 (0.036)
Fornix (L) 93 113 88 0.268 (0.090) 0.277 (0.063)
Cingulum (L) 101 96 109 0.231 (0.110) 0.286 (0.105)
Uncinate fasciculus (R) 70 147 62 0.305 (0.057) 0.431 (0.086)
Uncinate fasciculus (L) 109 142 59 0.274 (0.137) 0.309 (0.123)
Superior longitudinal fasciculus (L) 133 77 74 0.396 (0.145) 0.408 (0.146)
Inferior longitudinal fasciculus (R) 46 111 57 0.410 (0.070) 0.429 (0.069)
Inferior longitudinal fasciculus (L) 133 114 52 0.385 (0.119) 0.426 (0.084)
Inferior frontooccipital fasciculus (L) 119 179 67 0.218 (0.088) 0.253 (0.087)
Sagittal stratum (L) 126 86 80 0.545 (0.081) 0.570 (0.054)
Optic radiation (L) 111 34 77 0.213 (0.063) 0.220 (0.056)
Splenium of corpus callosum 85 94 88 0.799 (0.166) 0.801 (0.201)
Genu of corpus callosum 91 150 74 0.693 (0.179) 0.730 (0.160)
Body of corpus callosum 84 129 96 0.486 (0.155) 0.495 (0.161)
Anterior limb of internal capsule (L) 110 135 83 0.368 (0.101) 0.394 (0.117)
Posterior limb of internal capsule (R) 65 108 78 0.627 (0.085) 0.645 (0.102)
Posterior limb of internal capsule (L) 112 108 78 0.741 (0.053) 0.765 (0.053)
Thalamus (R) 81 117 84 0.370 (0.081) 0.374 (0.050)
Thalamus(L) 99 113 84 0.330 (0.044) 0.332 (0.061)
Anterior thalamic radiation (R) 82 116 71 0.451 (0.092) 0.486 (0.127)
Anterior thalamic radiation (L) 100 112 87 0.315 (0.057) 0.331 (0.057)
External capsule (L) 123 115 78 0.296 (0.050) 0.300 (0.065)
Superior parietal lobule (L) 100 82 122 0.208 (0.122) 0.228 (0.088)
Inferior parietal lobule (R) 40 84 91 0.333 (0.159) 0.343 (0.171)
Acustic radiation (R) 44 104 80 0.294 (0.123) 0.308 (0.127)
Acustic radiation (L) 128 95 78 0.462 (0.071) 0.472 (0.099)
Cerebellum (L) 128 61 41 0.210 (0.045) 0.238 (0.048)
Middle cerebellar peduncle (R) 74 94 35 0.248 (0.143) 0.277 (0.168)
Middle cerebellar peduncle (L) 102 93 35 0.277 (0.158) 0.315 (0.157)
Corticospinal tract (R) 79 109 51 0.5453 (0.126) 0.564 (0.093)
Corticospinal tract (L) 100 104 51 0.600 (0.139) 0.611 (0.168)
L: left. R: right.
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schizophrenia than in controls (Kakeda and Korogi, 2010;
Melonakos et al., 2011). White matter changes in patients with
schizophrenia have been explained by numerous theories (Ellison-
Wright and Bullmore 2009). According to one theory, disturbance
in white matter integrity is uniform in the brain, possibly due to
genetic abnormalities in the proteins that control myelination
(Konrad and Winterer, 2008). Several studies found abnormal
expression of myelin/oligodendrocyte-related genes in patients
with schizophrenia, suggesting a disruption in oligodendrocyte
function (Hakak et al., 2001; Tkachev et al., 2003; Sugai et al.,
2004; Dracheva et al., 2006). Another theory proposes that rather
than uniform white matter reduction, specific white matter tracts
are affected, either as a cause of or a consequence of a disorder in
the gray matter regions that they connect (Konrad and Winterer,
2008; Ellison-Wright and Bullmore, 2009). The results of the
present study show that FA was lower in the brain regions that
are components of specific white matter tracts important to the
pathophysiology of schizophrenia. The present findings confirmed
earlier reports of low FA in the superior longitudinal fasciculus
(Shergill et al., 2007; Seal et al., 2008), inferior longitudinal
fasciculus (Ashtari et al., 2007), inferior fronto-occipital fasciculus
(Seal et al., 2008), cingulate bundles (Takei et al., 2009), parietal
lobes (Ardekani et al., 2003; Chen et al. 2013), cerebellum and
middle cerebellar peduncles (Magnotta et al., 2008; Okugawa
et al., 2004) in patients with schizophrenia; on the other hand,
contrary to some earlier reports, FA of the corpus callosumwas not
significantly different compared with FA in the same region in
controls (Ardekani et al., 2003; Hubl et al., 2004; Roalf et al., 2013).
There are some previous studies in which no difference was found
in FA values of the corpus callosum, similar to our results
(Buchsbaum et al., 1998; Foong et al., 2002; Mandl et al., 2010).
Inconsistency is also present regarding laterality. There is still not
enough information to reach a conclusion about why some
findings are bilateral while others are unilateral. For any region
where there is a positive result, a negative result is also reported
(Kanaan et al., 2005; Ellison-Wright and Bullmore, 2009;
Melonakos et al., 2011). The heterogeneity of the disorder, clinical
variables such as severity and duration of illness, dose and
duration of previous antipsychotic use, and methodological differ-
ences such as ROI versus voxel-based approach have been
suggested to be responsible for the variance in reported results
(Kanaan et al., 2005). The most common interpretation of lower FA
is that it reflects lower white matter integrity (Kanaan et al.,
2005); however, our findings regarding low FA in multiple regions
do not specify the nature of the change. The density, diameter, or
directionality of the fibers, and the thickness of the myelin sheaths
all affect the diffusion of water molecules and, therefore, may be
responsible for the low FA observed in patients with schizophrenia
(Beaulieu, 2002).
An interesting result of the present study is that FA in the
patients with schizophrenia was higher in six regions, including
the right parahippocampus, posterior limb of the internal capsule,
sagittal stratum, left anterior thalamic radiation, and bilateral optic
radiation than in the controls at baseline. Although some studies
reported low FA in the parahippocampus (Ardekani et al., 2003),
bilateral posterior limb of the internal capsule (Skelly et al., 2008),
and left anterior thalamic radiation (Skelly et al., 2008), no study
has reported higher FA in these regions in schizophrenia patients
than in controls. On the other hand, higher FA was reported in
such regions as the arcuate fasciculus, superior longitudinal
fasciculus, and genu of the corpus callosum in patients with
schizophrenia with auditory hallucinations than in those without
auditory hallucinations and healthy controls (Hubl et al., 2004;
Shergill et al., 2007; Rotarska-Jagiela et al., 2009). High FA was
considered to be evidence of an increase in connectivity in these
regions and was suggested to be responsible for the occurrence of
hallucinations (Rotarska-Jagiela et al., 2009). Schizophrenia is a
heterogeneous disorder with a variable clinical picture and, as
such, differences in tissue abnormalities are not unexpected.
Clozapine treatment was indicated in the patients with schizo-
phrenia in the present study because they were refractory to other
previously used medications, and the higher FA in various brain
regions may have been related to the pathophysiology of refrac-
toriness, or the influence of the previously used antipsychotic
medications. Persistent psychotic symptoms may be the cause of
or the result of inappropriate or maladaptive wiring (Meyer-
Lindenberg, 2011). Considering the lower FA in multiple white
matter tracts observed in the present study, we think that higher
FA in other regions might be the result of compensatory mechan-
isms that evolved during the course of illness.
The most striking result of the present study is the significant
increase in FA values in multiple brain regions important to
interhemispheric and intrahemispheric connectivity after 12
weeks of clozapine treatment in the patients with schizophrenia.
Disturbances in the corpus callosum and the frontothalamic,
frontotemporal, cortical-thalamic-cerebellar-cortical pathways
have been reported in numerous studies. Those findings support
the dysconnection hypothesis of schizophrenia (Okugawa et al.,
2005; Okugawa et al., 2006; Ellison-Wright and Bullmore, 2009);
therefore, the FA increase in major white matter tracts following
12 weeks of clozapine treatment observed in the present study
suggests that clozapine might change white matter integrity and,
subsequently, connectivity in the regions associated with schizo-
phrenia. An interesting finding is that among the regions that were
significantly different between the patients and controls at base-
line, the left inferior fronto-occipital fasciculus and the superior
parietal lobule were the ones which had significantly increased FA
values after clozapine treatment. The lower FA at baseline seems
to be reversed in these regions, while FA values also increased in
several other regions which do not exactly overlap with those
showing group differences at baseline. Complicated neurodeve-
lopmental and neurodegenerative processes are thought to be
involved in the pathophysiology of schizophrenia and, as such, it
may not be reasonable to expect the structural and functional
disturbances to be fully reversible or treatable. On the other
hand, considering the plasticity of the brain and the possible
Fig. 3. Correlation between the change in FA values in left inferior fronto-occipital
fasciculus (LIFOF) and change in category fluency scores after 12 weeks of clozapine
treatment in patients with schizophrenia.
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neuroplastic effects of antipsychotics, reducing the severity of
symptoms via correction of dysconnectivity seems to be a possi-
bility (Konradi and Heckers, 2001). Our results suggest that the
alteration of connectivity may not only involve a reversal of the
disturbance in some regions, but also an adaptative or maladaptive
compensatory change in others. This may be a reason why, after
clozapine treatment, the FA values increased in several regions
other than the ones that differed from values in controls in the
baseline comparison.
The mechanism by which white matter microstructure chan-
ged in response to 12 weeks of clozapine treatment in the
present study remains unknown. A follow-up study that inves-
tigated the effect of antipsychotics on DTI measures reported that
there was a significant decrease in mean diffusivity (Do) in the
right pyramidal tract, left temporal lobe, and cingulate gyrus in
treatment responders after 28 days of antipsychotic (risperidone,
ziprasidone, or haloperidol) treatment, and an antipsychotic-
induced cascade was suggested to partially restore myelin integ-
rity and functional connectivity concomitant with the antipsy-
chotic effect (Garver et al., 2008). On the other hand in a recent
study, first episode, drug-naïve patients with schizophrenia were
reported to have a significant decrease in FA of white matter
around the bilateral anterior cingulate gyrus and the right corona
radiata of the frontal lobe, compared with healthy controls,
following 6 weeks of treatment with several typical and atypical
antipsychotics (risperidone, olanzapine, quetiapine, aripiprazole,
sulpiride, and haloperidol) (Wang et al., 2013). The authors
concluded that the acute reduction in white matter FA might be
due to the effects of antipsychotic medication during the early
phase of treatment, and discussed the potential toxic effects of
antipsychotic medication such as oxidative stress and excitatory
neurotoxicity, and also pointed out that it was not possible to
entirely exclude the effects of underlying progression of illness.
Our study is different from the previous longitudinal studies as it
includes a longer follow-up period, and specifically assesses the
effect of clozapine, which has not been studied previously. In
addition, the patients included in the present study were chronic
patients who had been treated previously, and had their baseline
assessment while they were on their current antipsychotic.
Therefore, the observed FA differences from controls at baseline
could have been exacerbated by the previous exposure to anti-
psychotics, and the increase in FA values in multiple white matter
tracts after 12 weeks of clozapine treatment could have resulted
from the switching of the patients’ current antipsychotic
medication.
Although the present study is the first to investigate the effect
of clozapine on white matter based on DTI measures, several
neuroimaging studies on the effect of clozapine on brain structures
and functions have been published (Molina Rodríguez et al., 1996;
Arango et al., 2003; Lahti et al., 2003; Ertugrul et al., 2009).
Clozapine was reported to increase the N-acetyl aspartate/creatine
ratio in the left dorsolateral prefrontal cortex after 8 weeks of
treatment, which was interpreted as evidence of the positive effect
of clozapine on neuronal function and integrity (Ertugrul et al.,
2009). Preclinical studies also suggest that there is a possible
neuroplastic effect of clozapine (Bai et al., 2003; Lu and Dwyer,
2005; MacDonald et al., 2005; Critchlow et al., 2006; Ozdemir
Rezaki et al., 2012), in addition to a protective role, on myelination
(Xu et al., 2009, 2010); as such, the change in axonal parameters,
in addition to increased myelination, might have played a role in
the observed increases in FA in the present study. The specific
effect of clozapine on FA measures could be better studied in first
episode drug naïve patients, but this is not possible in many
countries considering the current practice regarding initiation of
clozapine treatment only in patients with intolerance or resistance
to other antipsychotics.
The clinical importance of the increase in FA values in multiple
regions observed during clozapine treatment needs cautious
interpretation. Data on the relationship between DTI measures
and clinical variables are inconsistent (Peters et al., 2010). There
are several studies in which an inverse correlation was shown
between psychopathology and FA values (Skelly et al., 2008;
Nakamura et al., 2012), while others showed a positive correlation
(Karlsgodt et al., 2008; Cheung et al., 2011) or no correlation (Liu et
al., 2013). Wang et al. (2013) reported an improvement in positive
symptoms while FA decreased after 6 weeks of antipsychotic
treatment, but the correlation was not significant. They suggested
that in spite of the improvement in symptoms, antipsychotics
could not arrest or reverse a deteriorating process occurring in the
brains of patients with schizophrenia. Contrary to their results, in
the present study, PANSS scores improved while the FA increased
in several regions after 12 weeks of clozapine treatment, although
the correlations were not statistically significant. Besides, the
increase in FA values in the left inferior fronto-occipital fasciculus
was significantly correlated with the improvement in semantic
fluency. Since correlations cannot be assumed to reflect a causal
relationship, the improvement in semantic fluency after clozapine
treatment may not necessarily be a consequence of the increased
FA in this region. However, the inferior fronto-occipital fasciculus,
which connects occipital cortex to orbitofrontal and temporal-
basal regions, has been reported to have a crucial role in the
semantic system (Duffau et al., 2005; Martino et al., 2010), and the
correlation between low FA values in inferior fronto-occipital
fasciculus and the cognitive deficits has been shown in previous
studies (Lee et al., 2013; Liu et al., 2013). The observed relationship
between the change in FA values in the left inferior fronto-occipital
fasciculus and semantic fluency after clozapine treatment needs to
be confirmed in future studies. Although we do not know what the
increase in FA values actually mean at a microstructural level in
this study, considering that FA is accepted as a measure of white
matter integrity, and that it is consistently shown to be lower in
both first episode and chronic patients with schizophrenia com-
pared with controls (Ellison-Wright and Bullmore, 2009;
Nakamura et al., 2012; Lee et al., 2013), these results led us to
the conclusion that the increase in FA values, at least in some of
the regions such as the left inferior fronto-occipital fasciculus, after
12 weeks of clozapine treatment can be regarded as an
‘improvement’.
A strength of the present study was the use of TBSS to evaluate
whole-brain white matter, which is more informative than ROI
approaches which only analyze predetermined areas; however,
isotropic DTI with higher resolution would be obtained on a 3-
Tesla or higher system and that would likely yield more extensive
abnormalities. In the present study, FA was measured in an effort
to compare the present findings to those of previous studies on FA.
Investigation of other diffusion indices, such as axial and radial
diffusivity, would definitely yield more data about alterations in
brain tissue.
A shortcoming of the present study is the absence of a rescan of
the control group. A second DTI assessment of the controls at week
12 would have permitted a comparison of FA between patients on
clozapine and controls at week 12, and would enabled us to ensure
that the reported differences between the two measurements for the
patients with schizophrenia were due to the change in the type of
antipsychotic, rather than other factors, such as an alteration in FA
which might also be present in controls, or variations in technical
parameters. The results of previous longitudinal studies do not
support the probability of an increase in FA values of normal controls
in 12 weeks (Mitelman et al., 2009a, 2009b). Besides, we do not
expect a change in FA values due to technical factors since all DTI
scans were performed using the same scanner, which was not
upgraded during the study time period, with the same parameters,
E. Ozcelik-Eroglu et al. / Psychiatry Research: Neuroimaging 223 (2014) 226–235 233
carried out by the same technician, and were assessed by the same
radiologist. The study is also limited by the small sample size and
relatively low duration of follow-up. In fact, previous longitudinal
studies showed a change in FA values in patients with schizophrenia
even after 6–8 weeks of antipsychotic treatment (Garver et al., 2008;
Wang et al., 2013); therefore, a period of 12 weeks seems to be
reasonable to assess the effect of clozapine on FA values. However,
considering the long duration of illness, and the possible long-term
beneficial effects of clozapine treatment (Rosenheck et al., 1999), a
longer follow-up would ensure a more accurate assessment of the
effect of clozapine.
The present study is the first longitudinal study to investigate
the effect of clozapine on brain tissue via DTI and the first to assess
the relationship of post-treatment changes in FA with symptoms
and cognitive functioning in patients with schizophrenia. The
present findings support the current information on the role of
dysconnectivity in the pathophysiology of schizophrenia, and
suggest that clozapine changed white matter microstructure in
the corpus callosum and other brain regions involved in fronto-
thalamic, fronto-temporal, and cortical-thalamic-cerebellar-
cortical connectivity. These findings shed light on the unique
effect of clozapine in the treatment of schizophrenia, but they
must be confirmed by other large-scale, longer-term studies.
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